Bone mineral density, kidney function and participant‐reported outcome measures in women who switch from tenofovir disoproxil emtricitabine and a nonnucleoside reverse transcriptase inhibitor to abacavir, lamivudine and dolutegravir
| Image |  |
|---|---|
| Description | scientific article published on 5 December 2021 |
| Author/s |
author: Laura Waters Julie Fox Frank Post Shema Tariq Yvonne Gilleece |
| Publication date | December 5, 2021 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |